ArticlePsychopharmacology2022

Cannabinoid receptor type 1 antagonists alter aspects of risk/reward decision making independent of toluene-mediated effects.

Kevin M Braunscheidel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.